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Background: The radial forearm, free-ﬂap (RFFF)-reconstructed phonation tube was developed for
functional restoration of voice after total pharyngolaryngectomy. We aimed to report the efﬁcacy of RFFF
phonation tube after pharyngolaryngectomy with radiotherapy (RT) or concurrent chemoradiation
therapy (CCRT) with intensity-modulated radiotherapy (IMRT) for elderly.
Materials and methods: Ten patients with laryngeal and hypopharyngeal cancer underwent total phar-
yngolaryngectomy and one-stage reconstruction with an RFFF-accompanied phonation tube, followed by
RT or CCRT. Voice restoration was achieved with the RFFF-reconstructed phonation tube. Functional
outcomes of phonation and speech were evaluated and scored.
Results: Percentages of stage III and stage IV patients among all participants were 10% and 90%,
respectively. The median follow-up time was 31 months (range, 4e67 months). Almost 9 out of 10 (90%)
patients experienced phonation efﬁcacy greater than 80%. The maximal phonation time per breath was
70% longer than 3 sec. The graded as mild of wet voice was 90%. Percentage of mild decreased loudness
was 60% and that of low and high pitch was 80%. Of the 10 patients, 40% could count more than 10 and
70% could pronounce more than 1 to 5 words per breath. After RT or CCRT, of patients had moderately
good to excellent speech intelligibility.
Conclusion: The RFFF phonation tube that was used after pharyngolaryngectomy with RT or CCRT with
IMRT provided acceptable complications and functional restoration of voice for elderly patients.
Copyright  2013, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.terest.
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Since Theodore Billroth performed the ﬁrst laryngectomy for
cancer in 1873, loss of normal voice has been considered a pre-
dominant problem for more than 100 years. To overcome this
problem, a randomized trial1 and the Radiation Therapy Oncology
Group (RTOG) 91-11 trial2 proved similar survival rates between
total laryngectomy and organ preservation with radiotherapy (RT)
and chemotherapy. However, the recurrent rates of residual and
local tumors were higher in the chemotherapy induction group
than in the surgical group1. In addition, local failure rate was noted
to be greater than 20% in the RTOG 91-11 trial2. Surgery still plays
an important role in radical situations.
To restore the functions of voice, speech, and swallowing,
various reconstructive methods for the large defects of head andcy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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radial forearm free-ﬂap (RFFF), are available5. The jejunal ﬂap is a
popular choice because it already has a tubal structure and is
associated with relatively low rates of ﬁstula formation. However,
jejunal interposition requires an additional abdominal surgery,
which increases the risk of postoperative morbidity8,9. The tubal
RFFF has subsequently gained general acceptance with its good
defect repair and favorable swallowing outcome8,9. Nevertheless,
voice quality and functional intelligibility achieved using this
method are not as good as it should be for intelligible speech10,
especially when adjuvant RT or concurrent chemoradiation ther-
apy (CCRT) is needed due to the severity of locally advanced
disease11.
Intensity-modulated radiation therapy (IMRT) is highly
conformal, with sharp dose gradients from the target volume to
neighboring normal tissue, especially compared with conventional
RT12. Additionally, IMRT is associated with improved quality of life
among long-term survivors of head and neck cancer13. However,
despite recent advances in treatments for head and neck cancer, the
treatment paradigms in the elderly population have not been well
deﬁned. These patients may not be considered candidates for
aggressive multimodality management due to their multiple
comorbidities, general debility, poor treatment tolerance, and
toxicities.
Here, we report our experience with the RFFF phonation tube
(PT) reconstruction technique followed by RT or CCRT with IMRT,
focusing on the possibility of preserving functions of phonation and
speech in elderly patients, with limited complications.
2. Materials and methods
2.1. Patient selection and data collection
Retrospective patient data were collected with the approval of
the Institutional Review Board of Mackay Memorial Hospital. From
April 2005 to November 2011, ten patients with locally advanced
hypopharyngeal or laryngeal carcinoma underwent total phar-
yngolaryngectomy and one-stage reconstruction with an RFFF-
accompanied PT, followed by RT or CCRT.
2.2. Surgical procedures
All participants were treated by the same team of head and neck
surgeons and plastic surgeons11. Brieﬂy, the shape and size of the
RFFF were designed based on the size of the pharyngeal defect and
the expected length of the PT. After the harvest, it was rolled as a
connecting tube; one part was connected to the base of the
oropharynx, another part was connected to the proximal end of the
esophagus, and a third part was sutured near the tracheostoma.
2.3. Radiotherapy
IMRT was performed with a computed tomographic simulation
using the Eclipse planning system version 7.3.10 (Varian Medical
Systems, Palo Alto, CA, USA). RT was begun as soon as there was
adequate healing after surgery. Normally, this was within 4 weeks
after the procedure, but in no case RT was started later than
6 weeks postoperatively. Treatment was delivered once daily in ﬁve
fractions per week over 7 weeks, with all targets being treated
simultaneously. The surgical bed containing soft tissue invasion, or
regions with extracapsular extension of metastatic neck nodes,
received a radiotherapy dose of 64.8e66 grays (Gy). Clinical target
volume (CTV)59.4 primarily included high-risk nodal areas.
CTV52.8e56 was used for low-risk subclinical disease prophylaxis.Planning target volume (PTV) was created by adding a 3 mm
margin to CTV.
Planning for treatment was based on one phase (from skull base
to lower neck) using a dose-painting technique.
2.4. Chemotherapy
Patients who received chemotherapy were scheduled to un-
dergo two to three cycles of chemotherapy [containing cisplatin
(Abiplatin injection 0.5 mg/mL) 25 mg/m2/d and 5-ﬂuorouracil (5-
FU; ﬂuorouracil injection 50 mg/mL) 750 mg/m2/d infused
continuously for 5 days] concurrently with RT every 3e4 weeks.
2.5. Evaluation of phonation and speech intelligibility
The phonation and speech training was started about 3 weeks
postoperatively by a qualiﬁed speech language pathologist.
Phonation was obtained by covering the tracheostoma with the
thumb without occluding the external oriﬁce of the PT, forcing the
expiratory airﬂow through the PT into the neoesophagus. During
this study, phonation and speech outcomes were collected post-
operativelywithin 1month prior to RTor CCRT. Upon completion of
RT or CCRT, patients were evaluated every 3 months for the ﬁrst
2 years.
The phonation outcome data included the ability of voice pro-
duction, phonation efﬁcacy, maximal phonation time (MPT) per
breath, loudness, and grading of wet voice. Phonation efﬁcacy is the
success rate of producing voice. For assessing speech outcome, data
on number counting per breath, words spoken per breath, and
speech intelligibility were collected. Number-counting per breath
means how many numbers (from 1 to 10) can be counted in one
breath; similarly, words spoken per breath means howmanywords
can be spoken in one breath. These examinations are used to esti-
mate the amount of air streaming through the PT. However, it is
more difﬁcult to speak words than to count numbers. The scale
used for speech intelligibility evaluationwas similar to the one used
in our previous work11. Brieﬂy, on this scale, 1 ¼ not understand-
able, 2 ¼ occasionally understandable, 3 ¼ understandable when
the topic is limited, 4 ¼ occasionally not understandable, and
5 ¼ understandable. In the current study, speech intelligibility was
tested by groups of two to three single-syllable Chinese characters,
and was graded by one qualiﬁed speech language pathologist and
one resident. A total score of 8e10 was considered excellent speech
intelligibility, 5e7 moderately good, and 2e4 poor.
2.6. Evaluation for toxicities and treatment results
All patients were evaluated at least once a week during CCRT.
Upon completion of radiation, patients were evaluated every
3 months for the ﬁrst 2 years. At each follow-up visit, a complete
evaluation including clinical examination and bimanual palpation
of neck was performed. Post-treatment magnetic resonance im-
aging of the head and neck was done 1 month, 3 months, and
6 months after the completion of RT. Toxicities were deﬁned and
graded according to the Common Terminology Criteria for Adverse
Events v3.0 (CTCAE v3.0). The earliest date of detecting grade 3 or
worse toxicity was recorded.
2.7. Statistical analysis
Descriptive statistics were calculated to characterize the pa-
tients, diseases, and treatment features, as well as toxicities after
treatment. The overall survival, disease-free survival, locoregional
control, andmetastasis-free survival rates were estimated using the
KaplaneMeier product-limit method. Durations were calculated
Table 2
Acute toxicities for laryngeal or hypopharyngeal cancer patients treated with total
pharyngolaryngectomy and one-stage reconstruction with RFFF-accompanied
phonation tube, followed by radiotherapy or concurrent chemoradiation therapy.
Variablea Patients who received pharyngolaryngectomy
with an RFFF phonation tube followed
by CCRT
n ¼ 10 (%)
Mucositis
Grade 1 5 (50)
Grade 2 1 (10)
Grade 3 2 (20)
Grade 4 2 (20)
Grade 5 0
Dermatitis
Grade 1 3 (30)
Grade 2 3 (30)
Grade 3 4 (40)
Grade 4 0
Grade 5 0
Leucopenia
Grade 1 8 (80)
Grade 2 2 (20)
Grade 3 0
Grade 4 0
Total Pharyngolaryngectomy with RFFF Phonation Tube 87from the date of pathologic proof of cancer. All analyses were
performed using the SPSS, version 12.0 statistical software (SPSS
Inc., Chicago, IL, USA).
3. Results
3.1. Patient characteristics
Ten men were enrolled in the study. The median age was 65
years (range, 58e76 years). The subsets were laryngeal cancer
(n ¼ 4, 40%) and hypopharyngeal cancer (n ¼ 6, 60%). None expe-
rienced close or positive surgical margins. Of all patients, 10%
(n ¼ 1) had stage III disease, whereas 90% (n ¼ 9) had stage IV
disease. The median dose of radiation was 66 Gy (range, 64.8e66
Gy) and the median duration of complete RT or CCRT was 7 weeks
(range, 7e9 weeks). Patient characteristics are given in Table 1.
3.2. Treatment outcomes and toxicities
The median follow-up time was 31 months (range, 4e67
months). During RT or CCRT, there was no grade 3 acute toxicity forTable 1
Patient characteristics.
Variable Patients who received surgery with
radial forearm free ﬂap (n ¼ 10)
n (%)
Age (y)
Median 65
Range 58e76
Sex
Male 10 (100)
Subsite
Laryngeal carcinoma 4 (40)
Hypopharyngeal carcinoma 6 (60)
Pathology
Squamous cell carcinoma 10 (100)
Resection-margin status
Negative 10 (100)
Pathology stage
Tumor stage
Stage I 0
Stage II 0
Stage III 1 (10)
Stage IVA 8 (80)
Stage IVB 1 (10)
Primary tumor stage
T1a 0
T1b 0
T2 1 (10)
T3 4 (40)
T4a 5 (50)
T4b 0
Regional lymph node stage
N0 2 (20)
N1 1 (10)
N2a 0
N2b 0
N2c 6 (60)
N3 1 (10)
Treatment stratagem
Surgerya ➜ RT 3 (30)
Surgery ➜ CCRT 7 (70)
Radiotherapy dose (Gy)
Median (range) 66 (64.8e66)
Complete weeks
Median (range) 7 (7e9)
CCRT ¼ concurrent chemoradiation therapy; RT ¼ radiotherapy.
a Total pharyngolaryngectomy and one-stage reconstruction with a radial fore-
arm free ﬂap accompanied by a phonation tube.
Grade 5 0
Fistula formation
No 10 (100)
Yes 0
Leakage of phonation tube
No 8 (80)
Yes, prior to RT or CCRT 2 (20)
bToxicity of xelostomia (acute): acute toxicity is deﬁned as occurring <90 days after
beginning radiotherapy.
CCRT ¼ concurrent chemoradiation therapy; RFFF ¼ radial forearm free ﬂap;
RT ¼ radiotherapy.
a The grade of toxicity is according to the Common Terminology Criteria for
Adverse Events v3.0 (CTCAE v3.0).neutropenia. The rate of grade 3 dermatitis was 40% and that of
grade 4 mucositis was 20%. None of the patients suffered ﬁstula
formation after the completion of treatment, although two (20%)
patient experienced leakage of the PT after surgery (Table 2).
3.3. Phonation outcomes
Table 3 summarizes the phonation and speech outcomes at the
last follow-up prior to the writing of this report. The phonation
efﬁcacy was 80% or better for almost all patients (9/10, 90%). Sev-
enty percentage of patients experienced MPT more than 3 seconds.
Wet voice was graded as mild in 90% of patients. The percentage of
mild decreased loudness was 60%. Eighty percent of patients had
low or high pitch (Table 3, parts AeE).
3.4. Speech outcomes
For speech outcomes, 40% of patients counted more than 10
consecutive numbers per breath, and 70% of patients pronounced
1 to 5 words per breath. Additionally, 80% of patients had moder-
ately good to excellent speech intelligibility at the last follow-up
visit (Table 3, parts FeH).
4. Discussion
According to the RTOG 950114 and the European Organisation
for Research and Treatment of Cancer (EORTC 22931)15, these re-
ports conﬁrmed the beneﬁts of multiple modalities for patients
having locally advanced head and neck cancer, with intermittent
and high risk factors. However, the long-term follow-up data of
Table 3
Phonation and speech outcomes (1 month post operation/last follow-up) for laryngeal or hypopharyngeal cancer patients treated with total pharyngolaryngectomy and one-
stage reconstruction with radial, RFFF-accompanied by a phonation tube followed by RT or CCRT.
(A) Evaluation of phonation efﬁcacy at the last follow-up visit after RT or CCRT (n ¼ 10).
Phonation efﬁcacy (%) 100 90 80 70 60 50 40 30 20 10
n (%) 5 (50%) 1 (10) 3 (30%) 0 0 0 0 1 (10) 0 0
(B) Evaluation of MPT (in seconds) at the last follow-up visit after RT or CCRT (n ¼ 10).
MPT 1 s 3 s 5 s 20 s
n (%) 3 (30) 4 (40) 2 (20) 1 (10)
(C) Evaluation of wet voice at the last follow-up visit after RT or CCRT (n ¼ 10).
Wet voice Not available Mild
Patient number (%) 1 (10) 9 (90)
(D) Evaluation of loudness at the last follow-up visit after RT or CCRT (n ¼ 10).
Loudness Not available Mild decrease Moderate decrease Severe decrease
n (%) 1 (10) 6 (60) 2 (20) 1 (10)
(E) Evaluation of pitch at the last follow-up visit after RT or CCRT (n ¼ 10).
Pitch Not available Low High
n (%) 2 (20) 6 (60) 2 (20)
(F) Evaluation of number counting per breath at the last follow-up visit after RT or CCRT (n ¼ 10).
Number counting per breath Not available 1e5 1e10 >10
n (%) 1 (10) 5 (50) 2 (20) 2 (20)
(G) Evaluation of words spoken per breath at the last follow-up visit after RT or CCRT (n ¼ 10).
Words spoken per breath Not available 5
n (%) 3 (30) 7 (70)
(H) Evaluation of speech intelligibility at the last follow-up visit after RT or CCRT (n ¼ 10) (intelligibility was tested for groups of two to three single-syllable Chinese
characters and then was graded by one qualiﬁed speech language pathologist and one resident; a total score of 8e10 was considered excellent, 5e7moderately good, and
2e4 poor).
Speech intelligibility score Not available 2e4 (poor) 5e7 (moderate) 8e10 (excellent)
n (%) 2 (20) 0 6 (60) 2 (20)
CCRT ¼ concurrent chemoradiation therapy; MPT ¼ maximal phonation time; RFFF ¼ radial forearm free ﬂap; RT ¼ radiotherapy.
J.-C. Lee et al.88RTOG 9501 showed that 13.5% of patients experienced latent effects
in the pharynx, larynx, and esophagus16. The problems that need to
be considered in the case of elderly patients are their multiple
comorbidities, general debility, poor treatment tolerance, and
toxicities17.
The failure rate for free ﬂaps was 5e13.5%18e20 and themortality
rates were 5e20%20e22. Additionally, 13e38% of patients experi-
enced pharyngocutaneous ﬁstulas20,21,23. Although Wolf et al1 re-
ported no difference in overall survival rates, the surgery group
experienced lower recurrence rates for residual tumors (4%) and
local tumors (2%) than the induction chemotherapy group (9% and
12%, p ¼ 0.042 and 0.001, respectively). In the RTOG 91-11 trial, the
local failure rates for the induction chemotherapy and CCRT groups
were 35% and 20%, respectively2. In radical settings, proper design
of surgery still plays an important role in preserving quality of life.
The loss of normal voice is considered a critical problem of
quality of life for locally advanced laryngeal carcinoma after total
laryngectomy or laryngectomy combined with postoperative RT.
For patients treated with near-total laryngectomy, voice preserva-
tion was greater than 77% (in 67 out of 87 patients)24. Lewin et al25
reported that 78% of patients with anterolateral thigh ﬂaps used
their tracheoesophageal punctures to speak. In other studies, 30% of
patients were able to develop useful tracheoesophageal speech
after primary or secondary tracheoesophageal punctures26. Char-
acteristics of the skin ﬂap used for voice restoration include a
cutaneous lining, low wet voice quality, and no inherent secre-
tion27,28. Recently, we found that more than 65% of patients expe-
rienced improvement in speech with treatment by the RFFF PT
technique29. In the current study, 90% patients experienced
phonation efﬁcacy greater than 80%.
Although decreased MPT has been reported in near-total lar-
yngectomy patients30, we noted that 70% of our patients whoseMPT achieved longer than 3 seconds. Additionally, 90% of our pa-
tients had only mildly wet voices. Only 60% of patients experienced
the severely decreased loudness. The percentage of patients able to
make both low- and high-frequency pitches was 80% (Table 3).
These data supported our previous observation11. In our pre-
liminary report, most of our patients were observed to achieve
moderately good speech intelligibility11. In our current study, 80% of
patients had moderate to excellent speech intelligibility. Treatment
with the RFFF-accompanied PT followed by RT or CCRT with critical
organs sparing decreases the sequelae caused by RT and achieves
speech function restoration for elderly patients.
In other studies, grade 3 dermatitis occurred with adjuvant
CCRT at a rate of 3e29% for locally advanced head and neck can-
cer;14,31,32 the corresponding rate in the current study was 40%
(4/10). According to the RTOG 91-11, 97-03, and 99-14 clinical trials
of CCRT for locally advanced head and neck cancer, 43% of assess-
able patients had a severe late toxicity in associationwith advanced
T stage, laryngeal/hypopharyngeal primary site, and neck dissec-
tion after CCRT33. The occurrence of grade 3 dermatitis in our study
participants can be explained by the presence of advanced T stage
(T3 and T4, 90%, 9/10) and larynx/hypopharynx primary site.
Additionally, relatively small cases caused the higher percentage of
sever dermatitis in the current study could not be ruled out. Grade 3
mucositis, induced by chemotherapy, reportedly occurred in 30e
60% of patients14,15,32. In the current study, 20% of patients expe-
rienced grade 4 mucositis evenwith the use of IMRT technique. The
reason for this can partly be attributed to the concurrent chemo-
therapy. Still now, more than 20% of elderly patients, who are
receiving RFFF-accompanied PT followed by RT or CCRT, even using
IMRT techniques, have grade 3 dermatitis and mucositis, which
indicates that better supportive care is needed for these elderly
patients.
Total Pharyngolaryngectomy with RFFF Phonation Tube 89Because surgery, radiation, and/or chemotherapy may disrupt
lymphatic structure and damage soft tissue, leading to scar tissue
formation and ﬁbrosis, and further affect lymphatic function, pa-
tients with head and neck cancer may be at high risk for developing
secondary lymphedema34. IMRT was reported to not only maintain
the early improvements in quality of life but also magnify them
over time, when comparedwith three-dimensional conformal RT13.
In the current study, none of the patients had severe ﬁbrosis. The
possible reasons could be limited cases number and management
with IMRT. However, further studies are needed to conﬁrm the
beneﬁts of the IMRT technique.
There are some limitations to our current study. First, the small
case numbers and the retrospective study designmake it difﬁcult to
draw statistical conclusions. Second, the follow-up time was rela-
tively short so that any potential late effects were addressed
insufﬁciently. Third, the functional phonation and speech restora-
tion by the PT based on RFFF still has room for improvement.
Nonetheless, the advantages of one-stage reconstruction, good
phonation efﬁcacy, moderate to excellent speech intelligibility, and
no prosthesis-related problems provide surgeons with a reference
and evidence to justify the radical surgery for locally advanced
laryngeal and hypopharyngeal cancer patients.
In conclusion, the phonation efﬁcacy and speech intelligibility
attained with RFFF-accompanied PT after pharyngolaryngectomy
followed by RT or CCRT in elderly patients are acceptable. The
multiple modalities offer a practical reference for elderly laryngeal
and hypopharyngeal cancer patients.References
1. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction
chemotherapy plus radiation compared with surgery plus radiation in patients
with advanced laryngeal cancer. N Engl J Med. 1991;324:1685e1690.
2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and
radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med.
2003;349:2091e2098.
3. Seidenberg B, Rosenak SS, Hurwitt ES, et al. Immediate reconstruction of the
cervical esophagus by a revascularized isolated jejunal segment. Ann Surg.
1959;149:162e171.
4. Tai HC, Hsieh CH, Chao KS, et al. Comparison of radiotherapy strategies for
locally advanced hypopharyngeal cancer after resection and ileocolic ﬂap
reconstruction. Acta Otolaryngol. 2009;129:311e317.
5. Harii K, Ebihara S, Ono I, et al. Pharyngoesophageal reconstruction using a
fabricated forearm free ﬂap. Plast Reconstr Surg. 1985;75:463e476.
6. Mendelsohn M, Morris M, Gallagher R. A comparative study of speech after
total laryngectomy and total laryngopharyngectomy. Arch Otolaryngol Head
Neck Surg. 1993;119:508e510.
7. Benazzo M, Bertino G, Lanza L, et al. Voice restoration after circumferential
pharyngolaryngectomy with free jejunum repair. Eur Arch Otorhinolaryngol.
2001;258:173e176.
8. Anthony JP, Singer MI, Deschler DG, et al. Long-term functional results after
pharyngoesophageal reconstruction with the radial forearm free ﬂap. Am J
Surg. 1994;168:441e445.
9. Azizzadeh B, Yafai S, Rawnsley JD, et al. Radial forearm free ﬂap phar-
yngoesophageal reconstruction. Laryngoscope. 2001;111:807e810.
10. McAuliffe MJ, Ward EC, Bassett L, et al. Functional speech outcomes after lar-
yngectomy and pharyngolaryngectomy. Arch Otolaryngol Head Neck Surg.
2000;126:705e709.11. Yang CC, Lee JC, Wu KC, et al. Voice and speech outcomes with radial forearm
free ﬂap-accompanied phonation tube after total pharyngolaryngectomy of
hypopharyngeal cancer. Acta Otolaryngol. 2011;131:847e851.
12. Chao KS, Low DA, Perez CA, et al. Intensity-modulated radiation therapy in
head and neck cancers: the Mallinckrodt experience. Int J Cancer. 2000;90:
92e103.
13. Chen AM, Farwell DG, Luu Q, et al. Intensity-modulated radiotherapy is asso-
ciated with improved global quality of life among long-term survivors of head-
and-neck cancer. Int J Radiat Oncol Biol Phys. 2012;84:170e175.
14. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy
and chemotherapy for high-risk squamous-cell carcinoma of the head and
neck. N Engl J Med. 2004;350:1937e1944.
15. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or
without concomitant chemotherapy for locally advanced head and neck can-
cer. N Engl J Med. 2004;350:1945e1952.
16. Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the RTOG 9501/
Intergroup Phase III trial: postoperative concurrent radiation therapy and
chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J
Radiat Oncol Biol Phys. 2012;84:1198e1205.
17. Siddiqui F, Gwede CK. Head and neck cancer in the elderly population. Semin
Radiat Oncol. 2012;22:321e333.
18. Shaw WW. Microvascular free ﬂaps. The ﬁrst decade. Clin Plast Surg. 1983;10:
3e20.
19. Harii K, Ohmori K, Torii S, et al. Microvascular free skin ﬂap transfer. Clin Plast
Surg. 1978;5:239e263.
20. Coleman 3rd JJ, Tan KC, Searles JM, et al. Jejunal free autograft: analysis of
complications and their resolution. Plast Reconstr Surg. 1989;84:589e595.
discussion 596e598.
21. Bakamjian VY, Long M, Rigg B. Experience with the medially based deltopec-
toral ﬂap in reconstructive surgery of the head and neck. Br J Plast Surg.
1971;24:174e183.
22. Huguier M, Gordin F, Maillard JN, et al. Results of 117 esophageal replacements.
Surg Gynecol Obstet. 1970;130:1054e1058.
23. Dedo DD, Alonso WA, Ogura JH. Incidence, predisposing factors and outcome of
pharyngocutaneous ﬁstulas complicating head and neck cancer surgery. Ann
Otol Rhinol Laryngol. 1975;84:833e840.
24. Bernaldez R, Garcia-Pallares M, Morera E, et al. Oncologic and functional results
of near-total laryngectomy. Otolaryngol Head Neck Surg. 2003;128:700e705.
25. Lewin JS, Barringer DA, May AH, et al. Functional outcomes after circumferential
pharyngoesophageal reconstruction. Laryngoscope. 2005;115:1266e1271.
26. Varvares MA, Cheney ML, Gliklich RE, et al. Use of the radial forearm fas-
ciocutaneous free ﬂap and Montgomery salivary bypass tube for phar-
yngoesophageal reconstruction. Head Neck. 2000;22:463e468.
27. Robb GL, Lewin JS, Deschler DG, et al. Speech and swallowing outcomes in
reconstructions of the pharynx and cervical esophagus. Head Neck. 2003;25:
232e244.
28. Deschler DG, Gray ST. Tracheoesophageal speech following laryngophar-
yngectomy and pharyngeal reconstruction. Otolaryngol Clin North Am. 2004;37:
567e583.
29. Leu YS, Hsiao HT, Chang YC, et al. Ileocolic free ﬂap reconstruction, concomitant
chemotherapy and radiotherapy and assessment of speech and swallowing
function during management of advanced cancer of the larynx and hypo-
pharynx: preliminary report. Acta Otolaryngol. 2005;125:642e646.
30. Cakli H, Ozudogru E, Cingi E, et al. Near total laryngectomy: the problems
inﬂuencing functions and their solutions. Eur Arch Otorhinolaryngol. 2005;262:
99e102.
31. Gomez DR, Zhung JE, Gomez J, et al. Intensity-modulated radiotherapy in
postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys.
2009;73:1096e1103.
32. Hsieh CH, Kuo YS, Liao LJ, et al. Image-guided intensity modulated radiotherapy
with helical tomotherapy for postoperative treatment of high-risk oral cavity
cancer. BMC Cancer. 2011;11:37.
33. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late
toxicity after concurrent chemoradiation for locally advanced head and neck
cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582e3589.
34. Deng J, Ridner SH, Dietrich MS, et al. Prevalence of secondary lymphedema in
patients with head and neck cancer. J Pain Symptom Manage. 2012;43:
244e252.
